Effect of Jiawei Erchentang on Polycystic Change, Endocrine and Metabolism in Patients with Polycystic Ovary Syndrome

WANG De-jun; LI Lu-kai; ZHANG Hui

doi:10.13422/j.cnki.syfjx.2017240190

您当前的位置：

首页 >

文章列表页 >

Effect of Jiawei Erchentang on Polycystic Change, Endocrine and Metabolism in Patients with Polycystic Ovary Syndrome

更新时间：2024-01-04

- Effect of Jiawei Erchentang on Polycystic Change, Endocrine and Metabolism in Patients with Polycystic Ovary Syndrome
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 23, Issue 24, Pages: 190-195(2017)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2017240190
  CLC： R271.9
- Published：2017
- 稿件说明：
移动端阅览
WANG De-jun, LI Lu-kai, ZHANG Hui. Effect of Jiawei Erchentang on Polycystic Change, Endocrine and Metabolism in Patients with Polycystic Ovary Syndrome[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(24): 190-195.
DOI：

WANG De-jun, LI Lu-kai, ZHANG Hui. Effect of Jiawei Erchentang on Polycystic Change, Endocrine and Metabolism in Patients with Polycystic Ovary Syndrome[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(24): 190-195. DOI： 10.13422/j.cnki.syfjx.2017240190.

摘要

目的：探讨加味二陈汤对肾虚痰湿型肥胖型多囊卵巢综合征（polycystic ovarian syndrome，PCOS）患者卵巢多囊样改变、内分泌及代谢的影响。方法：选取2015年3月-2016年3月河南省中医院收治的肾虚痰湿型肥胖型PCOS患者157例，以该批患者为研究对象，按随机数字表法分为治疗组（78例），对照组（79例）。对照组PCOS患者给予醋酸环丙孕酮片，治疗组在此基础上给予加味二陈汤，两组均进行3个月经周期的治疗，结束后对两组患者疗效、卵巢多囊样改变、内分泌功能、糖脂代谢及脂肪细胞因子进行比较。结果：治疗组患者总有效率为94.87%，对照组为81.01%，治疗组高于对照组（P<0.05）；经过治疗，两组患者均较治疗前双侧卵巢体积与卵泡数目明显降低，且治疗组低于对照组（P<0.05）；经过治疗后两组患者均较治疗前促黄体生成激素（luteotropic hormone，LH），卵泡刺激素（follicle-stimulating hormone，FSH）与卵泡刺激素（Testosterone，T）水平明显降低，雌二醇（estradiol，E2）水平明显升高，且治疗组患者效果优于对照组（P<0.05）；经过治疗，两组患者在治疗前糖脂代谢指标糖化血红蛋白（hemoglobin Alc，HbA1c），空腹胰岛素（fasting insulin，FINS），胰岛素抵抗指数（insulin resistance index，HOMA-IR），总胆固醇（total cholesterol，TC），甘油三脂（triglycerid，TG）均较治疗前明显降低，且治疗后治疗组显著低于对照组（P<0.05）；通过治疗，两组患者均较治疗前内脂素（visfatin，VF），瘦素（leptin，LEP）水平明显降低，脂联素（adiponectin，APN）水平明显升高，且治疗组优于对照组（P<0.05）。结论：加味二陈汤对肾虚痰湿型肥胖型PCOS具有积极的治疗效果，可以改善患者多囊样改变、内分泌功能以及糖脂代谢，值得在临床上推广。

Abstract

Objective: To study the effect of Jiawei Erchentang polycystic change

endocrine and metabolism in patients with polycystic ovary syndrome (PCOS). Method: A total of 157 cases of PCOS patients treated in our hospital from March 2015 to March 2016 were selected in this study

and divided into two groups by the random number table

with 78 cases in clinical group and 79 in control group. Patients in control group were treated with cyproterone acetate tablets. In addition to the therapy of the control group

the clinical group was also given Jiawei Erchentang. Then efficacy

polycystic change

endocrine and metabolism were compared. Result: The total effective rate of control group was 81.01%

while that of clinical group was 94.87%

with a significant difference (P<0.05). Compared with before treatment

ovarian volume and ovarian follicle conditions of two groups after treatment decreased (P<0.05). Compared with control group

ovarian volume and ovarian follicle conditions of the experimental group were lower (P<0.05). Compared with before treatment

luteotropic hormone (LH)

follicle-stimulating hormone (FSH) and testosterone (T) of two groups after treatment decreased

while estradiol (E2) increased (P<0.05). Compared with control group

FSH and T of the experimental group were lower after treatment

while E2 was higher (P<0.05). Compared with before treatment

glucolipid metabolism indexes

including hemoglobin Alc (HbA1c)

fasting insulin (FINS)

insulin resistance index (HOMA-IR)

total cholesterol (TC)

triglycerid (TG) of two groups after treatment decreased (P<0.05). Compared with before treatment

visfatin (VF) and leptin (LEP) of two groups after treatment decreased

while adiponectin (APN) increased (P<0.05). Compared with control group

VF and LEP of the experimental group were lower after treatment

while APN was higher (P<0.05). Conclusion: Jiawei Erchentang has a better effect on PCOS

and can significantly improve polycystic change

endocrine and metabolism

thus is worth clinical promotion.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of Reduning Injection， Shenfu Injection Combined with Gefitinib on Proliferation， Stemness Characteristics and Metabolism of Non-small Cell Lung Cancer Cells

Cinnamomi Cortex Regulates Incretin Effect in Diabetic Rats

Suanzaoren Tang and Its Modified Formulas on Prevention and Treatment of Anxiety Disorders： A Review

Pharmacological Progress of Epimedium on Reproductive and Endocrine System

Effects of Sesamin on the Metabolism of Ethanol

Related Author

ZHANG Haibo

XIAO Zhenzhen

ZHU Yanjuan

YU Yaya

DING Lina

MA Changju

LEI Chenjing

LIU Yihong

Related Institution

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine （Guangdong Provincial Hospital of Chinese Medicine）

Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome

HongKong-Macao Joint Lab on Chinese Medicine and Immune Disease Research

The Second Clinical College of Guangzhou University of Chinese Medicine

School of Pharmacy， Guangxi University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰